Feed Top Reports Pricing

⌘K

16:33:18·1620d

SECFiling

SEC Form 10-Q filed by Osmotica Pharmaceuticals plc

OSMT· Osmotica Pharmaceuticals plc

Health Care

Original source

Companies

OSMT
Osmotica Pharmaceuticals plc
Health Care

Recent analyst ratings

Dec 23UpdateHC Wainwright & Co.$5.00
Nov 9UpdateJefferies$7.00
Sep 24UpdateCantor Fitzgerald$6.00

Related

NEWS1555d
Osmotica Pharma Announces Rebranding As RVL Pharma, Issues Q4 Sales Outlook
SEC1556d
Osmotica Pharmaceuticals plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
PR1556d
Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol "RVLP," Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance
NEWS1556d
Osmotica Pharmaceuticals Says Q4 Net Sales For UNPEEQ Targeted To Range From $20M-$25M
NEWS1556d
Osmotica Pharmaceuticals Announces Corporate Name Change to RVL Pharmaceuticals plc With New Ticker Symbol 'RVLP'
SEC1557d
Osmotica Pharmaceuticals plc filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
PR1557d
RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022
PR1568d
Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022